Australia markets open in 9 hours 41 minutes

Repro Med Systems, Inc. (KRMD)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.2100-0.0100 (-0.45%)
As of 09:30AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 96.92M
Enterprise value 78.90M
Trailing P/E 398.47
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.96
Price/book (mrq)2.78
Enterprise value/revenue 3.25
Enterprise value/EBITDA -10.54

Trading information

Stock price history

Beta (5Y monthly) 0.38
52-week change 3-48.02%
S&P500 52-week change 3-5.29%
52-week high 34.8300
52-week low 31.9000
50-day moving average 32.6705
200-day moving average 32.9703

Share statistics

Avg vol (3-month) 341.71k
Avg vol (10-day) 344.62k
Shares outstanding 544.87M
Implied shares outstanding 6N/A
Float 824.81M
% held by insiders 110.84%
% held by institutions 158.48%
Shares short (12 May 2022) 4231.71k
Short ratio (12 May 2022) 45.07
Short % of float (12 May 2022) 40.97%
Short % of shares outstanding (12 May 2022) 40.52%
Shares short (prior month 13 Apr 2022) 4255.62k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin -23.96%
Operating margin (ttm)-26.10%

Management effectiveness

Return on assets (ttm)-9.24%
Return on equity (ttm)-16.05%

Income statement

Revenue (ttm)24.3M
Revenue per share (ttm)0.55
Quarterly revenue growth (yoy)15.00%
Gross profit (ttm)13.77M
Net income avi to common (ttm)-5.82M
Diluted EPS (ttm)-0.1310
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)22.58M
Total cash per share (mrq)0.5
Total debt (mrq)4.56M
Total debt/equity (mrq)13.12
Current ratio (mrq)7.20
Book value per share (mrq)0.78

Cash flow statement

Operating cash flow (ttm)-3.47M
Levered free cash flow (ttm)-1.08M